Live Chat

Les CFD sont des instruments complexes et sont accompagnés d’un risque élevé de pertes financières rapides en raison de l’effet de levier. 76,3 % des comptes d’investisseurs particuliers perdent de l’argent en tradant des CFD avec ce fournisseur. Vous devez déterminer si vous comprenez comment fonctionnent les CFD et si vous pouvez vous permettre de courir le risque élevé de perdre votre argent.

Close

 Graphique en direct de Abbott

Informations

Weekly Search
Weekly
Daily
date Fermer change % Variation Ouvrir un compte Haut Bas

instr__news

Webhose 2024 Dec 20, 12:15

Abbott Labs : objectif de cours relevé, recommandation d'achat sur la base d'une gamme de produits solide Par Investing.com

Abbott Laboratories
Webhose 2024 Dec 13, 17:04

Abbott augmente son dividende trimestriel à 59 cents, en hausse de 7,3% Par Investing.com

Abbott Laboratories

Markets.com news

man writing inflation on line charts
Alec Malloy 2024 Aug 19, 16:05

Test News Article French Only

BoJ Matières premières
French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

Semaine à venir : Les résultats des élections françaises sont déterminants pour les marchés européens

Le Forex Indices
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

Semaine à venir : La France va-t-elle déclencher une crise de l'euro ?

CPI
Businessman pointing hologram online banking icon.
markets.com Support Team 2024 Jun 20, 16:00

Semaine à venir : Beaucoup de données et d'informations sur l'inflation

Le Forex Indices

Info

Spread

0.70

Spread (%)

0.6236 %

Effet de levier

1:5

Intérêt au jour le jour à l’achat

-0.0597 %

Intérêt au jour le jour à la vente

-0.0292 %

Devise

USD

Horaires de Trading

Markets closed

Mardi

14:31 - 20:59

Lundi

14:31-20:59

Mercredi

14:31-20:59

Jeudi

14:31-20:59

Vendredi

14:31-20:59

Compte de résultat

Ouvrir un compte

---

Fermeture précédente

---

Plus haut/plus bas des 52 dernières semaines

--- – ---

Capitalisation boursière

198266126336

Actions en circulation

1734460032

Date de rapport d'activité (suivante)

2013-01-02

instr__dividend_date

2025-02-14

instr__ex_dividend_date

2025-01-15

instr__forward_annual_dividend_rate

2.36

instr__forward_annual_dividend_yield

0.0207

EPS

3.29

Actions en circulation

Abbott Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

En savoir plus sur cet instrument

Actif
Vendre
Acheter
% Variation
Instruments connexes
Trustpilot
Live Chat